• Flanders Investment & Trade
  • Team Vesalius
Team Vesalius

Bruno Holthof

Dr. Bruno Holthof is the current CEO of Oxford University Hospitals and has been closely involved in Oxford’s research and clinical response to the COVID-19 pandemic.

Bruno Holthof

Oxford University Hospitals

Prior to that, Holthof headed the Antwerp Hospital Network, transforming it into the most profitable hospital group in Belgium. Before becoming a CEO, Holthof was a partner at McKinsey & Company. During that time, he served a wide range of healthcare clients in Europe and the US and gained significant expertise in the areas of strategy, organization and operations

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?